Literature DB >> 7974528

Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid.

C M Silva1, F E Powell-Oliver, C M Jewell, M Sar, V E Allgood, J A Cidlowski.   

Abstract

HeLa S3 cells that contain endogenous glucocorticoid receptors (GR) were treated with dexamethasone (DEX) for periods of time ranging from 24 h to 2 weeks or chronically over a 2-year period. Regulation of GR protein and mRNA were examined by affinity labeling, Western blotting, and Northern blotting. Relatively short-term treatment of cells with DEX for 24 or 48 h revealed more profound down-regulation of GR protein than of GR mRNA. However, by 2 weeks of DEX treatment, the levels of both receptor protein and mRNA were both maximally down-regulated. Cells that had been chronically DEX treated (for up to 2 years) had no measurable GR protein or mRNA. The down-regulation of receptor protein and RNA that occurred after 2 weeks of DEX treatment is completely reversible upon DEX removal, whereas reversibility did not occur with cells that had been chronically treated with DEX. Furthermore, transfection of a glucocorticoid responsive reporter plasmid into these chronically DEX-treated cells demonstrated that these cells were no longer responsive to steroid treatment. However, cotransfection of a plasmid encoding the human GR into these chronically DEX-treated cells resulted in restored production of GR and responsiveness to hormone, indicating that the defect in these cells occurs only at the receptor level.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7974528     DOI: 10.1016/0039-128x(94)90013-2

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  27 in total

1.  Lysine 419 targets human glucocorticoid receptor for proteasomal degradation.

Authors:  Andrew D Wallace; Yan Cao; Sindhu Chandramouleeswaran; John A Cidlowski
Journal:  Steroids       Date:  2010-07-07       Impact factor: 2.668

Review 2.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

3.  Alpha and beta glucocorticoid receptor mRNA expression in skeletal muscle.

Authors:  S H Korn; E Koerts-de Lang; G E Engel; J W Arends; E F Wouters; F B Thunnissen
Journal:  J Muscle Res Cell Motil       Date:  1998-10       Impact factor: 2.698

Review 4.  Checks and balances: The glucocorticoid receptor and NFĸB in good times and bad.

Authors:  Mandakh Bekhbat; Sydney A Rowson; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2017-05-11       Impact factor: 8.606

5.  Estradiol stimulates an anti-translocation expression pattern of glucocorticoid co-regulators in a hippocampal cell model.

Authors:  Sanjana A Malviya; Sean D Kelly; Megan M Greenlee; Douglas C Eaton; Billie Jeanne Duke; Chase H Bourke; Gretchen N Neigh
Journal:  Physiol Behav       Date:  2013-03-26

6.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Authors:  N Barden
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

7.  Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements.

Authors:  Sivapriya Ramamoorthy; John A Cidlowski
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

8.  Glucocorticoid receptor mRNA expression in peripheral blood mononuclear cells in high trained compared to low trained athletes and untrained subjects.

Authors:  M Bonifazi; M Mencarelli; V Fedele; I Ceccarelli; A Pecorelli; G Grasso; A M Aloisi; M Muscettola
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

9.  Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus.

Authors:  Juan Du; Min Li; Denghai Zhang; Xiaoyan Zhu; Weiwei Zhang; Wei Gu; Yinglu Feng; Xiaofeng Zhai; Changquan Ling
Journal:  Arthritis Res Ther       Date:  2009-07-14       Impact factor: 5.156

Review 10.  Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression.

Authors:  Nicholas Barden
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.